Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Novo Nordisk cuts guidance as weight-loss drug market competition grows

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth outlook for 2025 amid intensifying competition in the weight-loss drug markets.

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Shares of Eli Lilly just got walloped. So, is the company still the name to own in GLP-1s, or are the tables turning on this pharma giant?

Mutual Funds Gobble Up Eli Lilly Stock, Ge Vernova And A Wrestling Name

Mutual Funds Gobble Up Eli Lilly Stock, Ge Vernova And A Wrestling Name

Eli Lilly stock is in a long consolidation pattern and below a critical moving average.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Left-for-Dead Penny Stock Just Got a Major Boost. Should You Buy It Now?

This penny stock has received a big boost after reports of bankruptcy began to circulate.

Composite Rating For Eli Lilly Rises To 96

Eli Lilly saw an improvement in its IBD SmartSelect Composite Rating Monday, from 90 to 96.

Investors Business Daily

World Health Organization makes U-turn on weight loss jabs

The decision is a significant shift in the WHO’s approach to drugs like Wegovy

The Independent UK

Eli Lilly Bounces Back. Zepbound Taking A Back Seat To Novo Nordisk's Wegovy At CVS.

Eli Lilly bounces back on strong Q1 despite losing key battle in weight-loss drugs.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Trump hints at tariff reprieve for pharma companies that bring operations back to US

Trump hints at tariff reprieve for pharma companies that bring operations back to US

He suggests drugmakers would get ‘a lot of time’ to repatriate manufacturing before facing levies

The Guardian - UK

Dow Jones Rallies After Surprise Jobless Claims; Meta, Microsoft Surge On Earnings

Dow Jones Rallies After Surprise Jobless Claims; Meta, Microsoft Surge On Earnings

The Dow Jones rallied 200 points Thursday after a surprise jump in weekly jobless claims. Meta stock and Microsoft surged on earnings.

Investors Business Daily

Stocks Soar Before the Open on Upbeat Microsoft and Meta Results, More Big Tech Earnings on Tap

Stocks Soar Before the Open on Upbeat Microsoft and Meta Results, More Big Tech Earnings on Tap

June S&P 500 E-Mini futures (ESM25) are up +1.18%, and June Nasdaq 100 E-Mini futures (NQM25) are up +1.68% this morning as forecast-beating quarterly results from Microsoft and Meta boosted sentiment.

Viagra and Mounjaro panic-buying could explain Ireland's 200% export surge to U.S.

Viagra and Mounjaro panic-buying could explain Ireland's 200% export surge to U.S.

U.S. multinational activity propelled the Irish economy to 3.2% growth in the first quarter, as Trump fears come into focus.

Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions

Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions

Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of the drugs that have not been approved by the FDA

The Independent UK

2 ‘Strong Buy’ Stocks to Buy on Plans to Increase American Manufacturing

2 ‘Strong Buy’ Stocks to Buy on Plans to Increase American Manufacturing

Two checkered names from diverse industries are looking to bolster their manufacturing capabilities in the U.S. Here's how they stack up as investment ideas.

Trade war with China to hit US healthcare

Trade war with China to hit US healthcare

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Get all your
news in one place.

100’s of premium titles.
One news app.

Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY

Take a deep dive into Eli Lilly's latest clinical GLP-1 results that sent shares soaring. The company has a big opportunity to serve needle-phobic patients.

Investors Business Daily

Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill

Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.

Eli Lilly's Quarterly Earnings Preview: What You Need to Know

Eli Lilly is scheduled to report its first-quarter results next month, and analysts expect a significant double-digit earnings growth.

The Guardian - UK

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly Earns Membership In 95-Plus Composite Rating Club

The IBD SmartSelect Composite Rating for Eli Lilly rose from 87 to 97 Monday.

Goldman Sachs Just Upgraded This Blue-Chip Stock. Should You Buy It Now?

With a strong pipeline, this pharmaceutical powerhouse is positioning itself as a dominant force in the future of medicine.

The Independent UK

Daily weight-loss pill may work as well as Ozempic and could replace injections

Patients in a trial taking orforglipron lost an average of 7.2kg over nine months

Investors Business Daily

Dow Jones Futures: Netflix Earnings Crush Views After Weekly Market Losses. Palantir, MercadoLibre Setting Up.

The major indexes fell in the holiday-shortened week after hitting resistance. It's still a market correction. Netflix

Investors Business Daily

Stock Market Tumbles On Nvidia Export Curbs, Fed Chief Powell, UnitedHealth: Weekly Review

The stock market sold off this week, with Nvidia AI chip export curbs, UnitedHealth guidance and Fed chief Jerome Powell's comments in focus.

The Guardian - UK

New daily weight-loss pill shows success at clinical trial

Orforglipron also reduced blood sugar levels in participants with type 2 diabetes

Experimental daily pill found to aid weight loss in what could be alternative to jabs like Ozempic

Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top choice if it is approved.

People

136,673 stories

Mark Zuckerberg

Robert F. Kennedy Jr

Lars Fruergaard Jørgensen

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the White House

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

299,371 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play